article thumbnail

10 benefits of clinical trial home visits

Deltaclinical

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

article thumbnail

10 benefits of clinical trial home visits

Deltaclinical

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

10 benefits of clinical trial home visits

Deltaclinical

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

article thumbnail

10 benefits of clinical trial home visits

Deltaclinical

Home visits for clinical trials are becoming increasingly popular, as they offer a number of distinct benefits for both the patient and the provider. Improved patient retention in the study: When patients are more comfortable and less burdened by the study, they are more likely to stay enrolled in the trial.

article thumbnail

Complexity in Early Phase Clinical Trials with Dr. Oren Cohen?

Clinical Trial Podcast

To answer these two questions, regulatory authorities around the world require medical product manufacturers to conduct Phase I, also known as early phase clinical trials. The post Complexity in Early Phase Clinical Trials with Dr. The post Complexity in Early Phase Clinical Trials with Dr. Oren Cohen?

article thumbnail

Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine

The Pharma Data

and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. As part of the arrangement under OWS, representatives from NIAID, BARDA and Moderna are part of the oversight group that receives recommendations from the trial’s independent DSMB. El Sahly, M.D., Baden, M.D., Baden, M.D.,

article thumbnail

NIH begins clinical trial evaluating second COVID-19 booster shots in adults

The Pharma Data

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States. Vaccine manufacturers have previously studied some variant vaccine candidates and are currently conducting clinical trials of Omicron-specific vaccines.